These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23339052)

  • 61. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond.
    Ríhová B; Etrych T; Sírová M; Kovár L; Hovorka O; Kovár M; Benda A; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1027-40. PubMed ID: 20524698
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
    Omelyanenko V; Kopecková P; Prakash RK; Ebert CD; Kopecek J
    Pharm Res; 1999 Jul; 16(7):1010-9. PubMed ID: 10450924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
    Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
    J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
    Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
    J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates.
    Pan H; Sima M; Kopecková P; Wu K; Gao S; Liu J; Wang D; Miller SC; Kopecek J
    Mol Pharm; 2008; 5(4):548-58. PubMed ID: 18505266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.
    Pan H; Sima M; Miller SC; Kopečková P; Yang J; Kopeček J
    Biomaterials; 2013 Sep; 34(27):6528-38. PubMed ID: 23731780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synergistic effect of EMF-BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma.
    Říhová B; Etrych T; Šírová M; Tomala J; Ulbrich K; Kovář M
    J Drug Target; 2011 Dec; 19(10):890-9. PubMed ID: 21981636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1).
    Duncan R; Coatsworth JK; Burtles S
    Hum Exp Toxicol; 1998 Feb; 17(2):93-104. PubMed ID: 9506260
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel dual stimuli-responsive ABC triblock copolymer: RAFT synthesis, "schizophrenic" micellization, and its performance as an anticancer drug delivery nanosystem.
    Davaran S; Ghamkhari A; Alizadeh E; Massoumi B; Jaymand M
    J Colloid Interface Sci; 2017 Feb; 488():282-293. PubMed ID: 27837719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates.
    Yang J; Luo K; Pan H; Kopečková P; Kopeček J
    React Funct Polym; 2011 Mar; 71(3):294-302. PubMed ID: 21499527
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.
    Greco F; Vicent MJ; Penning NA; Nicholson RI; Duncan R
    J Drug Target; 2005; 13(8-9):459-70. PubMed ID: 16332571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.
    Peng ZH; Sima M; Salama ME; Kopečková P; Kopeček J
    J Drug Target; 2013 Dec; 21(10):968-80. PubMed ID: 24160903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
    Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
    J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
    Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H; Etrych T; Ríhová B; Kostka L; Starovoytová L; Kovář M; Ulbrich K
    Macromol Biosci; 2013 Dec; 13(12):1648-60. PubMed ID: 24031022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
    Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
    Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells.
    Greco F; Vicent MJ; Gee S; Jones AT; Gee J; Nicholson RI; Duncan R
    J Control Release; 2007 Jan; 117(1):28-39. PubMed ID: 17129632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.